Jacobson Pharma Corporation Limited (2633) Declines -1.25% on Apr 5

Shares of Jacobson Pharma Corporation Limited (HKG:2633) last traded at 1.58, representing a move of -1.25%, or -0.02 per share, on volume of 218,000 shares. After opening the trading day at 1.59, shares of Jacobson Pharma Corporation Limited traded in a close range. Jacobson Pharma Corporation Limited currently has a total float of 2.02B shares and on average sees 939,937 shares exchange hands each day. The stock now has a 52-week low of 1.48 and high of 2.16.

HSI: A Powerful Asian Economy Indicator

The Asian economy is rampantly growing and it is countries such as Singapore, Hong Kong, Japan, and China that are leading the whole Asian equity market. Singapore and Hong Kong, for example, have recently been named by CG Watch as the top two countries in Asia with the best corporate governance in 2016. These countries are home to two of the most influential stock exchanges in the world, the Singapore Exchange (SGX) and the Stock Exchange of Hong Kong (SEHK). Both are subjects of Jacobson Pharma Corporation Limited interest.


With a total market capitalization of HK$24.68 trillion and a listing of nearly 2,000 companies as of 2015, the SEHK is Asia’s third biggest stock exchange and the world’s sixth biggest stock exchange. It was established in 1891 with its benchmark index, the Hang Seng Index (HSI), being first published in 1969.

Since that time all companies, like Jacobson Pharma Corporation Limited want to see their names in SEHK lists. Regular trading on the SEHK starts at 9:30 a.m. and lasts until 4:00 p.m. Meanwhile, pre-market trading lasts for 30 minutes starting at 9:00 a.m.

The HSI measures the top 50 companies on the SEHK, representing more than half of its total market capitalization. Its foundation is the brainchild of Ho Sin Sang, Hang Seng Bank (HSB) Chairman; Lee Quo-wei, HSB Director; and Stanley Kwan, HSB Head of Research. Primarily, they had founded the HSI to serve as the Dow Jones Industrial Average (HSI) of Hong Kong.

The components of the HSI are classified into four sectors since January 1985. These sectors include Utilities, Materials, Financials, and Energy— the biggest sector.

For a company to be eligible as a component of the HSI, it must belong to both the top 90% of the total market capitalization of common shares and total turnover on the SEHK, respectively. It must also be listed on the SEHK at least 24 months prior to the review date. Exceptions apply to companies that exhibit compelling market capitalization and liquidity. The same goes for Jacobson Pharma Corporation Limited company. In such cases, companies can already be eligible as components even if they have just been listed on the SEHK for three months prior to the review date, which happens quarterly.

HSI Performance

The HSI had posted its all-time low of 58.61 in August 1967. In December 1993, it had first attained the 10,000 mark. In December 2006, it had first attained the 20,000 mark.

Before the Global Financial Crisis of 2008 broke out, the HSI had first attained the 30,000 mark in October 2007. As a result, the HSI had posted its all-time high of 31,638.22 during the same month. The massive gains during that time are highly attributed to investors flocking safe-haven equity markets such as that of Hong Kong in anticipation of the Global Financial Crisis of 2008.

A year after attaining its all-time high, the HSI had lost more than 67%, falling back to the 10,000 mark in October 2008. In July 2009, the HSI had slowly recouped, attaining the 20,000 mark once again. It was highly appreciated by Jacobson Pharma Corporation Limited and its investors.

With a rich history backing the success and potentials of the SEHK, it is a guarantee that investors will gain interesting returns from their investments in Hong Kong’s equity market.

More recent Jacobson Pharma Corporation Limited (HKG:2633) news were published by: which released: “Is Fidelity Advisor Semiconductors I (FELIX) a Strong Mutual Fund Pick Right Now? – Yahoo Finance” on February 15, 2019. Also Seekingalpha.com published the news titled: “Tianjin Zhong Xin Pharmaceutical: Discount To A-Shares And Peers Should Narrow Over Time – Seeking Alpha” on April 25, 2017. ‘s news article titled: “Wall Street’s stock market forecasters agree — 2018 will be great – Yahoo Finance” with publication date: November 20, 2017 was also an interesting one.

Jacobson Pharma Corporation Limited, through its subsidiaries, makes and trades in generic drugs and proprietary Chinese medicines in Hong Kong. The company has market cap of $3.19 billion. The firm offers generic drugs for various therapeutic categories, including respiratory, cardiovascular, central nervous system, gastrointestinal, scar treatment, and oral anti-diabetics, as well as dermatologicals, anti-infectives, eye drops, vitamins, and minerals. It currently has negative earnings. It also provides proprietary Chinese medicines, such as Po Chai pills, Ho Chai Kung Tji Thung San, Tong Tai Chung Woodlok oil, Saplingtan, Shiling oil, Col-gan tablet, Contractubex scar gel, and Doan's ointment.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.